STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

[Form 4] LivaNova PLC Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4
Rhea-AI Filing Summary

LivaNova PLC (LIVN) director Donald Zurbay was granted 2,560 Restricted Stock Units (RSUs) on September 15, 2025. Each RSU converts to one ordinary share under the LivaNova PLC 2025 Director Incentive Award Plan. The grant carries vesting and forfeiture restrictions that are scheduled to lapse on June 15, 2026, subject to continued service and the award agreement. The reported RSUs have a $0 per-unit reported grant price on the Form 4 and are shown as directly beneficially owned following the award. The Form 4 was signed on behalf of the reporting person by an Attorney-in-Fact on September 17, 2025.

Positive
  • Grant disclosed: Reporting person was granted 2,560 RSUs on 09/15/2025 under the 2025 Director Incentive Award Plan
  • Alignment of interests: RSUs vest on 06/15/2026, creating a time‑based link between director service and share ownership
Negative
  • None.

Insights

TL;DR: A routine director equity grant: modest size, time‑based vesting aligns director incentives with shareholders.

The Form 4 discloses a standard director compensation event: 2,560 RSUs awarded to Director Donald Zurbay under the 2025 Director Incentive Award Plan, vesting on June 15, 2026 subject to continued service. Such awards are common governance practice to align board members with long‑term shareholder value. The filing reports direct beneficial ownership post‑grant and shows a $0 reported price per unit, consistent with RSU accounting where shares are delivered upon vesting rather than purchased. This disclosure is procedurally important for transparency but appears non‑material in isolation for company valuation.

TL;DR: Filing meets Section 16 reporting requirements for an insider equity award; timing and signature present required details.

The Form 4 contains required elements: reporting person identity and address, relationship to issuer (Director), transaction date (09/15/2025), instrument type (RSUs), number granted (2,560), vesting/forfeiture date (06/15/2026), and signature by an Attorney‑in‑Fact on 09/17/2025. The entry lists the ownership form as Direct. From a compliance perspective, the disclosure is complete and consistent with standard insider reporting for time‑based RSU grants.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person*
Zurbay Donald

(Last) (First) (Middle)
20 EASTBOURNE TERRACE

(Street)
LONDON X0 W2 6LG

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
LivaNova PLC [ LIVN ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
09/15/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Restricted Stock Units $0(1) 09/15/2025 A 2,560 (2) (2) Ordinary Shares 2,560 $0 2,560 D
Explanation of Responses:
1. Each Restricted Stock Unit ("RSU") represents a contingent right to receive one ordinary share of the Company, GBP 1.00 par value, in accordance with the terms of the LivaNova PLC 2025 Director Incentive Award Plan (the "Plan") and the award agreement.
2. On September 15, 2025, reporting person was granted RSUs to vest and forfeiture restrictions thereon to lapse on June 15, 2026, subject to continued service during the vesting period and the award agreement.
Remarks:
/s/ Sarah K. Mohr, Attorney-in-Fact 09/17/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did LivaNova director Donald Zurbay report on Form 4 (LIVN)?

The Form 4 reports a grant of 2,560 Restricted Stock Units (RSUs) to Donald Zurbay on 09/15/2025.

When do the RSUs granted to the director vest?

The RSUs are scheduled to vest and forfeiture restrictions lapse on 06/15/2026, subject to continued service and the award agreement.

Under which plan were the RSUs granted?

The award was made under the LivaNova PLC 2025 Director Incentive Award Plan as stated in the Form 4.

How many ordinary shares will the RSUs convert into?

Each RSU represents a contingent right to one ordinary share, so the 2,560 RSUs correspond to 2,560 ordinary shares upon vesting.

What price was reported for the RSU grant on the Form 4?

The Form 4 reports a $0 per‑unit price for the RSU award, reflecting that RSUs are granted rather than purchased.
Livanova Plc

NASDAQ:LIVN

LIVN Rankings

LIVN Latest News

LIVN Latest SEC Filings

LIVN Stock Data

2.94B
54.41M
0.38%
103.73%
3.63%
Medical Devices
Electromedical & Electrotherapeutic Apparatus
Link
United Kingdom
LONDON